ABSTRACT A monoclonal antibody, CC11.23, with monomorphic specificity predominantly for products of the HLA-DQ subregion, has been used to demonstrate primary structural variation among DQ molecules. Two cell lines of each haplotype (DRI-7) were radiolabeled with [3Htyrosne.
Polymorphism is a hallmark of the molecules encoded within the major histocompatibility complex (MHC) of humans and other mammals. The exact role(s) of this polymorphism is still unknown, but it may be to enhance the capacity of the immune system to respond to a wide variety of antigens. Within the human MHC, a comparison of the molecules encoded by the HLA-DR subregion from several different human B-cell lines shows that the molecules possess a nonpolymorphic a chain and a polymorphic f3 chain (1, 2).
HLA-DQ § molecules are encoded near the HLA-DR subregion and are also polymorphic. This polymorphism has been suggested at several different levels by a variety of techniques (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . The finding that the serological markers DQwl, DQw2, and DQw3 reside on DQ molecules (8, (12) (13) (14) further strengthened early arguments that the DQw supertypic specificities represented an allelic series separate and distinct from HLA-DR.
Like DR (3 chains, which are highly polymorphic, DQ m chains also display allelic variation. For example, Goyert and Silver showed by two-dimensional gel electrophoresis that DQ 8 chains varied in electrophoretic mobility depending upon the haplotype from which the chains were derived (6) . More recently, it was demonstrated at the primary structural level that DQ molecules that bear the t)Qw3 (MB3) de- terminant from DR4 cell lines have (3 chains distinct from those DQ molecules that bear the DQw3 determinant in DRS cell lines (7) .
Although the DR a chain appears to be nonpolymorphic
(1), a growing body of evidence suggests that the DQ a chain is polymorphic (8) (9) (10) (11) . Comparisons of genomic and/or cDNA sequences of DQ a chain from several cell lines have demonstrated that multiple differences exist among the few haplotypes examined (9, 10) . Polymorphic variation of both the a and ( chain of the DQ molecule is consistent with the extensive polymorphism exhibited by its murine counterpart, the I-A molecule. Both the a and (8 chains of I-A molecules display variation from one haplotype to another (15) . In addition to these extensively polymorphic I-A chains, the mouse expresses a modestly polymorphic I-E a chain and a highly polytnorphic I-E (3 chain. A similar situation appears to exist within the human counterpart ofI-E, the HLA-DR subregion. Existing data are consistent with the notion that the DR a chain is invariant, or at best only modestly variant, but that the DR ( chain, the DQ a chain, and the DQ P chain are polymorphic among different haplotypes.
Shortly after the demonstration of allelic polymorphism of murine class II molecules, evidence was presented for the formation of hybrid molecules in F1 animals, providing a possible molecular mechanism for the phenomenon of gene complementation (16, 17) . This trans gene complementation increases the alloantigen repertoire in heterozygotes. In humans, tranls association has recently been reported for DQ molecules by two-dimensional gel electrophoresis (18 (20) . HLA-DQ antigens were isolated by passage of the glycoprotein pool over a CC11.23 antibody affinity column. The adherent antigens were eluted with 1.5 M ammonium thiocyanate in Tris-buffered saline (0.01 M Tris/0.15 M NaCl, pH 7.5). From some of the cell lines HLA-DR antigens were isolated from a portion of the glycoprotein pool by passage over an L203 or IIIE3 antibody affinity column. Pools of eluted antigens were dialyzed against the Tris-buffered saline, and the antigens were recovered by precipitation with 10 volumes of cold acetone. NaDodSO4/Polyacrylamide Gel Electrophoresis. Affinitypurified CC11.23-and L203-reactive radiolabeled antigens were electrophoresed under reducing conditions on NaDodSO4/12.5% polyacrylamide tube gels (26) . The gels were fractionated into 0.05% NaDodSO4 in water, and aliquots of each sample were assayed for radioactivity to determine the positions of the a-and (-chain polypeptides. Appropriate fractions were pooled and dialyzed against distilled water before amino acid sequence analysis.
Amino Acid Sequence Determination. (1, 2) . In this report the nature of this polymorphism has been examined by determining amino-terminal tyrosine sequences of (3 chains isolated from two cell lines of each DR haplotype (DRJ-7). Most of these chains were isolated by using the DR-reactive monoclonal antibody L203, but a few were isolated with monoclonal antibody IIIE3. Several studies were done with both, and no differences were detected. Two cell lines of each DR haplotype were used to insure that any variation demonstrated represented an allelic difference and not a random point mutation. We found allelic polymorphism among the DR ( chains, examining only amino-terminal tyrosine sequences (Table 1) . Of the seven haplotypes examined, only two of the (3 chains had identical tyrosine sequences (DR2 and DR4), providing evidence for a minimum of six allelic forms of DR (3 chains. The DR2 and DR4 ( chains can be distinguished from one another by utilizing an additional amino acid (valine) (2) .
HLA-DQ a Chains, Unlike HLA-DR et Chains, Are Polymorphic. Just as others have demonstrated that the DR a chain is nonpolymorphic (1, 2), all DR a chains isolated in this study possessed a tyrosine at position 13 (data not shown). In contrast to these results with DR a chains, the sequence results of DQ a chains (Table 2) demonstrates the existence of multiple alleles of the locus for the DQ a-chain. While positions 16 and 19 are invariant among all of the haplotypes studied, these a chains can be placed into three groups according to the presence or absence of tyrosines at positions 11 and/or 25.
HLA-DQ fi Chains Are Polymorphic. Like the DR (3 chains, the DQ ( chains also display variable amino-terminal tyrosine residues. The amino-terminal tyrosine sequences of two DQ ( chains from each DR haplotype (DR1-7) are shown in Table 3 26 (DRS/7) was exactly as predicted from the repetitive yield line and was identical in sequence to that seen in DR4/4 or DRS/S homozygotes. These data demonstrate at the primary structural level that both the DQ4 (or 5) and the DQ7 a chains are found associated with the DQ4 (or 5) P chain in these heterozygotes. 
DISCUSSION
This study documents primary structural variation among both the a and / polypeptide chains of HLA-DQ subregionencoded molecules. The variation correlates with the DR haplotype and, thus, represents allelic polymorphism. This study was possible because of the availability of a monoclonal antibody, CC11.23, which recognizes DQ molecules in all human lymphoblastoid B-cell lines studied thus far. Like many of the HLA-D region-specific monoclonal antibodies described to date, CC11.23, in several circumstances, also recognizes other HLA-D products in addition to DQ molecules. For example, in some cell lines CC11.23 is reactive with a population of molecules consisting of 10-50% DR molecules and 50-90% DQ molecules. These two populations of molecules are easily distinguishable from one another because of the differences in positions of their amino terminal tyrosine residues in both their a and (3 chains (31) .
A rather surprising finding of this study was the ease of demonstrating allelic polymorphism by examining only the amino termini of DQ molecules with a single amino acid. It should be noted that by using this same amino acid, tyrosine, it has been possible not only to distinguish each of the different subregion products [i.e., a and 8 chains of DP(SB), DQ, and DR (31) ] but also most of the alleles at the locus for the DR (-chain ( Table 1) . The ability to show a considerable amount of allelic polymorphism examining only amino terminal tyrosine positions may have important implications about the residues comprising the allodeterminants of a given haplotype. Neither the allelic polymorphism of the HLA-DQ chains nor the polymorphism seen in DR chains would be detected using most other amino acids in aminoterminal sequencing. This hypothesis that tyrosine residues near the amino terminus may contribute to allospecificity may be used to explain why very few, if any, DRw6-specific alloantisera exist. From examination of the available primary structural data of the DRw6 chains (see Table 1 ), it is obvious that these chains are distinct in that they have only one, or lack altogether, amino-terminal tyrosines. Likewise, in the murine system, comparison of the amino-terminal amino acid sequences of I-A /3 chains from strain b mice with strain d mice reveals only 5 amino acid differences in their amino-terminal 50 residues; 4 of these 5 differences involve tyrosine substitutions (32). Thus, it is possible that tyrosine residues in the amino termini of class II molecules are important in generating allodeterminants.
A minimum of three allelic forms of HLA-DQ a chains and five allelic forms of HLA-DQ /3 chains (Tables 2 and 3 The amino acid sequences that have been reported for the DQ molecules bearing the supertypic specificities DQwl (12) and DQw3 (13) through use of monoclonal antibodies Genox 3.53 and IVD12, respectively, are identical to the sequences reported here using antibody CC11.23. We recently have shown that the DQw3-bearing DQ molecule isolated from two homozygous DR4 lines was distinct from the DQw3-bearing DQ molecule from two homozygous DR5 lines (7).
The present study extends these findings by suggesting that each of the DQ supertypic specifities (i.e., DQwl, DQw2, and DQw3) can be further subdivided into at least two distinct subsets based on their polymorphic DQ P chains. For example, the DQw3 supertypic specificity resides on both the DQ4 and DQ5 molecules, yet these molecules have different 13 chains.
A growing body of evidence at both the DNA and protein level suggests that there are two DQ-like molecules in at least some cell lines (10, 30, 33) . In none of the sequences reported in this study was (30) . This also supports the hypothesis presented above that particular amino-terminal tyrosine residues may be important in forming allodeterminants. Second 20 distinct allotypes have been mapped to the I-A subregion serologically (15) . The apparent lack of DQ-specific alloantisera in humans does not exclude the possibility that the human HLA-DQ subregion will be at least as polymorphic as the mouse I-A subregion. Thus far, any DQ allele-specific alloantisera that exist would probably have been designated as DR-specific alloantisera. In fact, recent evidence suggests that such DQ alloantisera do exist, either as solely DQ-specific sera or in conjunction with DRspecific alloantisera (34) . Such DQ allele-specific alloantisera should be important reagents in studying large groups of cell lines, normal individuals, and patients, allowing clearer interpretations regarding linkage relationships between the HLA-DR and HLA-DQ subregions and, in particular, closer correlations of disease associations with one or the other gene product.
Finally, these techniques for demonstrating allelic polymorphism of DQ a and /8 chains have provided an approach to study the formation of hybrid molecules in heterozygotes, confirming the earlier findings in the mouse (16, 17) and human (18) that trans gene complementation can occur in at least certain combinations. In this study the DQ7 a chain has been shown to associate with either the DQ4 or DQ5 3 chains to form a hybrid heterodimer. The implications of these findings, although uncertain at present, could be important in terms of responsiveness to particular antigens and/or susceptibility to certain diseases. For example, insulin-dependent (type I) diabetes mellitus is a disease with complex HLA-D region associations. The disease is associated with two DR alleles: DR3 (relative risk of 3.3) and DR4 (relative risk of 6.4). In homozygous individuals the relative risk increases to 10 for DR3 and 16 for DR4. Interestingly, the highest relative risk is found for individuals who are DR3/4 heterozygous (relative risk of 33) (35) . If the increased susceptibility to insulin-dependent diabetes mellitus is, in fact, more closely related to alleles of HLA-DQ rather than alleles of HLA-DR, the formation of hybrid DQ molecules in DR3/4 heterozygotes and the attendant implications of these particular heterodimers in the immune response process might be a plausible explanation for the increased relative risk for DR3/4 heterozygotes.
Many questions remain concerning the broader implications of trans gene complementation in the HLA-D region; nonetheless, these studies demonstrate that, in addition to the serologically and biochemically defined MB supertypic specificities and the electrophorectic variation previously seen among DQ molecules, there are primary structural differences that distinguish a minimum of six distinct DQ molecules. This high level of polymorphism has important implications not only for disease susceptibilities and tissue transplantation but also for the evolution of the MHC itself.
